{"artifact_id":"wiki-investment-antibody-therapeutics-neurodegeneration","artifact_type":"wiki_page","title":"Antibody Therapeutics Investment Landscape for Neurodegeneration","quality_score":0.5,"is_latest":1,"version_number":1,"version_count":1,"debate_count":0,"supports_count":0,"contradicts_count":0,"neutral_count":0,"incoming_by_type":{"related":224,"see_also":322},"total_incoming":546,"outgoing_by_type":{"related":214,"see_also":322,"mentions":169},"total_outgoing":705,"quality_trajectory":[],"evidence_balance":0.0,"evidence_certainty":1.0,"total_evidence_items":1251,"is_well_supported":false,"is_controversial":false,"is_foundational":false}